Data updated: May 26, 2026
XIMINO (minocycline hydrochloride)
Dermatology
Approved 2012-07-11
1
Indication
--
Phase 3 Trials
13
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2012-07-11
- Patent Cliff
- 2027
- Routes
- ORAL
- Dosage Forms
- CAPSULE, EXTENDED RELEASE
XIMINO Approval History
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
15 FDA actions from 2012 to 2026
What XIMINO Treats
1 FDA approvalsOriginally approved for its first indication in 2012 .
- Other (1)
📋
Clinical Trial Registry
5 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT06246396 | IRB202301939 2R01HL132448-05A1 | Ph 4 | recruiting | Antihypertensive Mechanisms of Minocycline in Resistant Hypertension |
| NCT05826912 APT-TBI-01 | APT-TBI-01 | Ph 2 | enrolling by invitation | Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury |
| NCT02203552 results posted | OSU-13165 NCI-2014-00851 | Ph 2 | completed | Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer |
| NCT02297412 results posted | RU221408I NCI-2016-01592, RU221408I | Ph 2 | completed | Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel |
| NCT04076098 | RP139-02/18 | Ph 4 | completed | Locally Delivered Minocycline in Advanced Periodontitis |
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
XIMINO FDA Label Details
View full patent landscape →
3 OB patents · 3 families ·
32 international docs across 11 countries
Pro Intelligence Preview
Deep insights for XIMINO
Revenue Insights
- • Quarterly revenue tracking
- • Historical trend analysis
Patent Timeline
- • Cliff: 2027
- • 45 active patents
Trial Analysis
- • Clinical trial tracking
- • Development stage analysis
Competitive Landscape
- • Competitor tracking
- • Same target/indication analysis
Unlock Full Intelligence
Full approval history • All patents • Revenue trends • Competitor analysis
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.